90 results
DEFC14A
DMKPQ
DMK Pharmaceuticals Corp
12 Oct 23
Proxy in contested solicitation
4:22pm
, the Nominating and Governance Committee considers a variety of factors, including: (i) reputation for integrity, honesty and high ethical standards; (ii
PREC14A
DMKPQ
DMK Pharmaceuticals Corp
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
a variety of factors, including: (i) reputation for integrity, honesty and high ethical standards; (ii) demonstrated business acumen, experience
424B4
DMKPQ
DMK Pharmaceuticals Corp
3 Aug 23
Prospectus supplement with pricing info
4:55pm
result in substantial costs and diversion of management attention and resources, which could significantly harm our profitability and reputation.
If our … regulatory authorities. Any of these matters could adversely affect our business, reputation, revenues, results of operations, financial condition
8-K
EX-3.1
bmpa2id67hfh
26 May 23
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
4:25pm
DEFM14A
mzx7c7q92 csm
13 Apr 23
Proxy related to merger
4:52pm
DEFC14A
faaeq8opfikx
14 Jun 21
Proxy in contested solicitation
6:01am